METACARE CO., Ltd. (KRX:118000)
327.00
-14.00 (-4.11%)
Last updated: Apr 18, 2025
METACARE CO. Revenue
In the year 2024, METACARE CO. had annual revenue of 20.21B KRW with 17.10% growth. METACARE CO. had revenue of 5.60B in the quarter ending December 31, 2024, with 25.26% growth.
Revenue
20.21B
Revenue Growth
+17.10%
P/S Ratio
2.67
Revenue / Employee
918.55M
Employees
22
Market Cap
53.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20.21B | 2.95B | 17.10% |
Dec 31, 2023 | 17.26B | -1.84B | -9.64% |
Dec 31, 2022 | 19.10B | 484.98M | 2.61% |
Dec 31, 2021 | 18.61B | 11.99B | 181.12% |
Dec 31, 2020 | 6.62B | -49.53B | -88.21% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
Peptron | 3.15B |
LigaChem Biosciences | 125.90B |